Company: RNLXY
Filing Date: 2025-01-16
Form Type: 8-K
Source: 0001213900-25-004220
Chunk: 0

Company: Renalytix plc
Filing Date: 2025-01-16
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01. Regulation
FD Disclosure

Renalytix plc (the “ Company”) has determined that, at December
31, 2024, the last business day of the Company’s most recently completed second fiscal quarter, it qualified as a “foreign
private issuer” (“ FPI”) as defined in Rule 405 under the Securities Act of 1933, as amended. The Company previously
qualified as an FPI. However, since July 1, 2023, the Company had filed as a domestic reporting company. Effective January 1, 2025, the
Company will cease filing periodic reports and registration statements with the Securities and Exchange Commission on U. S. domestic issuer
forms but will instead file its reports as an FPI.

SIGNATURES